[ad_1]
Abu DhabiUnited Arab Emirates, June 5, 2023 /PRNewswire/ — Ministry of Health — Abu Dhabi The UAE’s healthcare sector regulator (DoH) has signed a partnership statement with global healthcare leader Eli Lilly and Company.as the capital united arab emiratesThis partnership has strengthened Abu Dhabi To be a leading destination in healthcare and life sciences by seeking to establish a framework for clinical research, real-world evidence and healthcare technology collaborations.
Statement on DoH partnership with Eli Lilly (PRNewsfoto/Department of Health – Abu Dhabi)
Statement on DoH partnership with Eli Lilly (PRNewsfoto/Department of Health – Abu Dhabi)
Witnessed by HE Mansoor Al Mansoori, Chairman of the Ministry of Health – Abu Dhabi (Ministry of Health) and Leigh Ann PusseyExecutive Vice President of Corporate Affairs and Communications at Lilly, the partnership announcement was made by PhD Asma MannayExecutive Director, Center for Research and Innovation, Department of Health – Abu Dhabi and Irina ZaporozhetsVice President and General Manager middle East at Eli Lilly.
PhD Asma Mannay said: “Through international cooperation, Abu Dhabi Seeking to lead a research group supported by global partners exploring resilience and sustainability in the global healthcare industry and delivering quality care to patients. Under the direction of our wise leadership, Abu Dhabi The transformative journey of the region is being paved through innovation, life sciences and valuable partnerships with global players in the field. Department of Health- Abu Dhabi (DoH) is proud to partner with Lilly to further improve healthcare outcomes while providing patients with quality care and breakthrough treatments Abu Dhabi beyond. “
The parties will drive clinical research and life sciences activities in the emirate, with a focus on oncology, diabetes and neurological diseases, while utilizing Abu Dhabi Evolving healthcare and life sciences infrastructure and capabilities.
Irina Zaporozhets Said: “Our work with the Ministry of Health — Abu Dhabi Reflects Lilly’s strong commitment to expanding access to our medicines and fostering innovation to improve the efficiency and effectiveness of healthcare delivery. “
Led by the DoH, a Abu Dhabi delegation visit U.S. between June 1Yingshi2023 and June 8day2023 showcases partnership opportunities in the UAE and explores collaborations with leading organizations in R&D, manufacturing and health innovation.
The mission of the delegation will be to bostonjust in time Abu Dhabi Join Bio International 2023 to showcase the growth and development of the UAE’s biotech industry.
About the Department of Health – Abu Dhabi (Ministry of Health):
DoH is the regulatory body for the healthcare industry in the UAE Abu Dhabi And ensure excellence in healthcare for the community by monitoring the health of the population. The DoH defines the health system’s strategy, monitors and analyzes the health status of the population and the performance of the system. In addition, the DoH develops the health system’s regulatory framework, examines regulations, enforces standards, and encourages the adoption of world-class best practices and performance targets for all healthcare providers in the emirate. DoH also promotes programs to increase awareness and adoption of healthy living standards among Emirate residents Abu Dhabi In addition to regulating the scope of services, premiums and reimbursement rates of the health system.
For more information on DoH, please visit https://www.doh.gov.ae/ and continue Twitter , instagram, Facebook, LinkedIn and youtube.
photo – https://mma.prnewswire.com/media/2092398/DoH_Eli_Lilly_1.jpg
photo – https://mma.prnewswire.com/media/2092399/DoH_Eli_Lilly_2.jpg
Media Contact:
rania el kebe
+971551038650
[email protected]
Source Department of Health – Abu Dhabi
[ad_2]
Source link